Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001003642-17-000092
Filing Date
2017-11-09
Accepted
2017-11-09 16:10:53
Documents
101
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ipxl-09x30x2017x10q.htm 10-Q 1994545
2 EXHIBIT 31.1 ipxl-09x30x2017x10qxexx311.htm EX-31.1 13231
3 EXHIBIT 31.2 ipxl-09x30x2017x10qxexx312.htm EX-31.2 13424
4 EXHIBIT 32.1 ipxl-09x30x2017x10qxexx321.htm EX-32.1 8004
5 EXHIBIT 32.2 ipxl-09x30x2017x10qxexx322.htm EX-32.2 7069
  Complete submission text file 0001003642-17-000092.txt   12293807

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ipxl-20170930.xml EX-101.INS 2863834
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ipxl-20170930.xsd EX-101.SCH 87418
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ipxl-20170930_cal.xml EX-101.CAL 109218
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ipxl-20170930_def.xml EX-101.DEF 542823
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ipxl-20170930_lab.xml EX-101.LAB 1085022
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ipxl-20170930_pre.xml EX-101.PRE 695156
Mailing Address 30831 HUNTWOOD AVENUE HAYWARD CA 94544
Business Address 30831 HUNTWOOD AVENUE HAYWARD CA 94544 510-240-6000
IMPAX LABORATORIES INC (Filer) CIK: 0001003642 (see all company filings)

EIN.: 650403311 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34263 | Film No.: 171190923
SIC: 2834 Pharmaceutical Preparations